Document is current

Any future updates will be listed below

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE

Crossref DOI link: https://doi.org/10.1136/lupus-2023-001007

Published Online: 2023-12-19

Published Print: 2023-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark